Osivax publishes positive results from trial of influenza vaccine candidate - Pharmafile
Summary by pharmafile.com
1 Articles
1 Articles
Osivax publishes positive results from trial of influenza vaccine candidate - Pharmafile
French biopharma, Osivax, has announced positive results from its phase 2 study, OVX836-004, into OVX836, its broad-spectrum influenza vaccine lead candidate. The results have been published in the journal, Vaccines. In the study, 180 healthy adults aged 18 to 55 years were given either Fluarix Tetra (hemagglutinin antigen-based inactivated influenza vaccine) with a placebo, Fluarix […] The post Osivax publishes positive results from trial of i…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium